Synopsis of recent research by authors named "Kengo Yamakawa"
- Kengo Yamakawa's recent research emphasizes the clinical implications of misdiagnosis in neuropsychiatric symptoms caused by underlying metabolic disorders, such as insulinoma, showcasing the importance of comprehensive diagnostic evaluation in psychiatric settings.
- His work also highlights rare cases of drug-induced hypocarnitinemia leading to hypoglycemia in adults, underlining the need for awareness of potential adverse drug reactions, particularly in patients with pre-existing conditions.
- Additionally, Yamakawa has contributed to understanding the role of Wnt3a and AMPK in the regulation of VEGF synthesis in osteoblasts, implicating metabolic pathways in bone health and providing insights for therapeutic targets in related conditions.
